KBC appeared to be the Corporate Investor, which was created in 1935. The main department of described Corporate Investor is located in the Brussels. The fund was located in Europe if to be more exact in Belgium.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the KBC, startups are often financed by Gimv, Life Sciences Partners, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Gimv, Life Sciences Partners, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Life Sciences Partners, Gimv.
The top activity for fund was in 2009. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this KBC works on 12 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year.
Among the most successful fund investment fields, there are Clinical Trials, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Fnality International, CitizenLab, Aristo Music Technology For fund there is a match between the location of its establishment and the land of its numerous investments - Belgium. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
|2M||22 Dec 2020||Belgium, Antwerpen|
|3M||02 Jun 2020||Luxembourg, Luxembourg|
|1M||15 Jul 2019||Belgium, Leuven|
|2M||11 Aug 2017|
|589K||18 Nov 2016||Belgium, Brussels|
|4M||20 Jan 2012||Belgium, Ghent|
|4M||11 Feb 2010||Netherlands, Rotterdam|
|8M||05 Nov 2009|
|13M||10 Sep 2009||Netherlands, Rotterdam|
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.